Related Experiment Video

Updated: Jul 23, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

[Cerebral palsy and epilepsy in children]

Emira Svraka1, Slobodan Loga

  • 1Srednja skola za medicinske sestre-tehnicare Jezero, Sarajevo.

Medicinski Arhiv
|July 7, 2005
PubMed

Insights

Maternal illnesses during pregnancy increase the risk of epilepsy in children with cerebral palsy (CP). This study found a 1.6 times higher probability of epilepsy in children whose mothers experienced illnesses during pregnancy.

Area of Science:

  • Neurology
  • Pediatrics
  • Epidemiology

Context:

  • Cerebral palsy (CP) is a motor disorder resulting from damage to the developing brain.
  • CP can co-occur with various other conditions, including epilepsy, intellectual deficits, and sensory impairments.
  • Understanding prenatal risk factors is crucial for early intervention in CP.

Purpose:

  • To investigate the influence of prenatal etiological factors on learning difficulties in children and adolescents with cerebral palsy.
  • To determine the association between maternal illnesses during pregnancy and the development of epilepsy in individuals with CP.

Summary:

  • This retrospective prospective cohort study analyzed 80 children and adolescents (ages 6-20) with CP in Canton Sarajevo.
  • Mothers who experienced illnesses during pregnancy had a 1.59 times higher risk of their children developing epilepsy.
  • Epilepsy was present in 53.3% of children exposed to maternal illness during pregnancy, compared to 34% in the unexposed group.

Impact:

  • Identifies maternal illness during pregnancy as a significant risk factor for epilepsy in children with cerebral palsy.
  • Highlights the need for enhanced prenatal care and monitoring for pregnant women with risk factors for CP.
  • Provides epidemiological data to inform public health strategies and clinical management of cerebral palsy and its comorbidities.

More Related Videos

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy08:24

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy

Published on: August 11, 2023

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.